Cell Marque

Diagnostic grids

Fellow Pathologists- In these times of exciting and rapid change in the field of immunohistochemistry, Cell Marque brings many new products to market. With this are applications involving the newer antibodies as well as new data on applications involving established antibodies. As the applications grow, so too do the diagnostic grids. I hope they are of some assistance as a quick reference. Keep in mind that not all indicated tumors of a specified category will fit the indicated immunohistochemical pattern, and there is no substitute for familiarity with the literature dealing with these products.

-Michael G. Lacey, MD.

Carcinomas
Lymphomas
B-Cell Lymphomas
T-Cell Lymphomas
Acute Myeloid Leukemia
Lymphoblastic Lymphomas, BCL vs. TCL
Plasma Cells
Lymph Node Histiocytosis
Histiocytic Lesions
Histiocytic Proliferation
Immunoglobulin, Heavy and Light Chain
B-Cell, Maturation
High Grade Lymphoma, BCL vs. TCL
Follicular Lymphoma vs. Reactive Follicles
Mastocytosis
Splenic Hematopoietic Proliferations
Organ Specific
Pancreatic Tumors
Brain: CNS Tumors
Kidney: Renal Epithelial Tumors
Breast Carcinoma
Breast vs. Lung vs. Prostate Carcinoma
Differential Diagnosis of Parathyroid Tumors
Sex Cord Stromal Tumors
Uterus: Trophoblastic Cells/Proliferations
Skin: Adnexal Tumors
Breast Lesion
Meningiomas from Histologic Mimics
Renal Cell Carcinoma vs. Hemangioblastoma
Ovarian Carcinomas
Skin: Pagetoid Tumors
Skin: Basal vs. Squamous Cell Carcinoma
Perineurioma vs. Neurofibroma
Breast CA in-situ vs. Infiltrating Breast CA
Pancreas vs. Pancreatic Adenocarcinoma





Options:

Select Country:
Select Background:

Random

"Shaken"

"Marie"

"Rabbit"

"Maiden"

"Immuno"

"Purpose"

"Life"

Share this page:

Email